Literature DB >> 17842433

In Reply: Amplification c-erbB-2 and Aggressive Human Breast Tumors?

D J Slamon, G M Clark.   

Abstract

Entities:  

Year:  1988        PMID： 17842433     DOI： 10.1126/science.240.4860.1796

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

1.  Oncogenes and human breast cancer.

Authors:  J M Hall; P J Zuppan; L A Anderson; B Huey; C Carter; M C King
Journal:  Am J Hum Genet       Date:  1989-04       Impact factor: 11.025

2.  Loss of heterozygosity on chromosome 1q in human breast cancer.

Authors:  L C Chen; C Dollbaum; H S Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 3.  Genomic and proteomic biomarkers for cancer: a multitude of opportunities.

Authors:  Michael A Tainsky
Journal:  Biochim Biophys Acta       Date:  2009-05-04

4.  Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features.

Authors:  U Lönn; S Lönn; B Nilsson; B Stenkvist
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

5.  C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis.

Authors:  H C Parkes; K Lillycrop; A Howell; R K Craig
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

6.  Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas.

Authors:  F R Hirsch; M Varella-Garcia; W A Franklin; R Veve; L Chen; B Helfrich; C Zeng; A Baron; P A Bunn
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

7.  HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials.

Authors:  Michael F Press; Guido Sauter; Marc Buyse; Hélène Fourmanoir; Emmanuel Quinaux; Denice D Tsao-Wei; Wolfgang Eiermann; Nicholas Robert; Tadeusz Pienkowski; John Crown; Miguel Martin; Vicente Valero; John R Mackey; Valerie Bee; Yanling Ma; Ivonne Villalobos; Anaamika Campeau; Martina Mirlacher; Mary-Ann Lindsay; Dennis J Slamon
Journal:  J Clin Oncol       Date:  2016-10-10       Impact factor: 44.544
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.